The latest online buzz about cosmetic medicine:
DEATH BY LIPOSUCTION
A 32-year-old mother of three died after an April 14 liposuction operation in Texas. The medical examiner says the liposuction by a board-certified plastic surgeon punctured the patient’s aorta.? Liposuction often is a safe operation, but it is not free of risks. Other liposuction-related deaths have included:
PLASTIC SURGERY AT A DISCOUNT
A man who is not a licensed physician as been indicted on charges of illegally performing cosmetic procedures on several women whom he examined at spas and beauty salons in New York, but operated on in the Dominican Republic. Some of the women reportedly were disfigured by the unlicensed treatments.
JEANS THAT FIGHT CELLULITE?
The latest of many unproven treatments for cellulite is a pair of blue jeans infused with green tea, which a French company says helps to fight the ripply skin? that women hate so much.
FDA EYES LIP INJECTIONS
The dermal filler Restylane is often injected to make lips plumper, but that use has never been approved by the Food and Drug Administration. Now its maker, Medicis Pharmaceutical of Scottsdale, Ariz., is seeking official FDA approval for Restylane as a lip-plumper, but the FDA staff is unhappy with the study that Medicis conducted.
SEEKING SIZE 6, 4, OR 2?
A new technology is taking aim at vanity sizing, offering a true measurement of the various sizes that different clothing retailers use. But the reason stores’ labels are unreliable is that women like to purchase clothes labeled with a smaller-than-expected size. Is there really any chance that this technology will catch on — that women will be happy to find clothes sized accurately instead of sized to make them feel good about their girth?
Join the conversation: Follow “In Your Face” on Twitter and Facebook for the latest information, discussions and gossip about cosmetic medicine, celebrities and regular people. To stay up-to-date, you can also subscribe to this blog for free by email or by RSS feed.
More online buzz:
No comments:
Post a Comment